Contrast Media Injectors

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a cause of contrast-induced nephropathy (CIN). This has raised concern in recent ...

There have been several recent advances with contrast media injector technology, including cutting costs by reducing contrast waste and automated data collection for the dose a patient receives. Automated injector systems not only precisely control the amount of contrast used; vendors have moved into the software/IT arena by offering personalized doses for patients using information pulled from an electronic medical record (EMR) or picture archiving and communication system (PACS). Contrast dose recording software also offers new possibilities for radiology departments looking to streamline and document their contrast media usage. Some vendors have now integrated X-ray radiation dose recording capabilities as well.

Bracco Diagnostics Inc. announced the availability of its Isovue (iopamidol injection) Imaging Bulk Package (IBP), a specific combination multi-patient, multi-dose compliant contrast medium approved by the U.S. Food and Drug Administration (FDA) for point-of-care use in the computed tomography (CT) suite.

Guerbet announced a worldwide launch of FlowSens, a contrast agent injection solution used in X-ray medical examinations. FlowSens received CE marking in the first quarter of 2014. It will initially be marketed in Europe (first in Belgium, France, Germany and Switzerland), then gradually in other regions of the world.